Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 13, 2013

Primary Completion Date

March 19, 2013

Study Completion Date

March 19, 2013

Conditions

Constipation

Interventions

DRUG

Polyethylene glycol (MiraLAX, BAY81-8430)

Oral solution, 17g polyethylene glycol, one time

DRUG

Mannitol

Oral, 2g, 4g, 6g, 8g and 10g mannitol, one time

Trial Locations (1)

Merck Consumer Center, Memphis